1h Free Analyst Time
Global Protein Therapeutics Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The protein therapeutics market is poised to grow by $ 82.47 bn during 2020-2024 progressing at a CAGR of 7% during the forecast period. The reports on protein therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased demand for mAbs and the availability of favorable reimbursement policies.
The protein therapeutics market analysis includes product segment and geographic landscape.
The protein therapeutics market is segmented as below:
By Product
- mAbs
- Human insulin
- Erythropoeitin
- Clotting factors
- Others
By Geographic Landscapes
- North America
- Europe
- APAC
- South America
- MEA
This study identifies the development of novel therapies using innovative technologies as one of the prime reasons driving the protein therapeutics market growth during the next few years.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The protein therapeutics market covers the following areas:
- Protein therapeutics market sizing
- Protein therapeutics market forecast
- Protein therapeutics market industry analysis.
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading protein therapeutics market vendors that include AbbVie Inc., Amgen Inc., AstraZeneca Plc, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Novo Nordisk AS, Pfizer Inc., and Sanofi. Also, the protein therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Product
Market segmentation by Therapy Area
Market segmentation by Protein Function
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global protein therapeutics market: AbbVie Inc., Amgen Inc., AstraZeneca Plc, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Novo Nordisk AS, Pfizer Inc., and Sanofi.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the development of novel therapies using innovative technologies."
According to the report, one of the major drivers for this market is the increased demand for mAbs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca Plc
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson
- Merck & Co. Inc.
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi
